ERBB2 and breast cancer: In addition, the study revealed that Her-2 overexpression and basal-like types had a higher histological grade and greater cell proliferation capability as compared with other subtypes of breast cancer, indicating poor prognosis of the Her-2 overexpression and basal-like types.